US20100056762A1
(en)
*
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
BR122018071808B8
(pt)
|
2003-11-06 |
2020-06-30 |
Seattle Genetics Inc |
conjugado
|
MX2007001470A
(es)
*
|
2004-08-05 |
2007-03-26 |
Genentech Inc |
Antagonistas anti-cmet humanizados.
|
ES2715776T3
(es)
*
|
2004-11-12 |
2019-06-06 |
Seattle Genetics Inc |
Auristatinas que tienen una unidad de ácido aminobenzoico en el extremo N
|
EP2322623A3
(en)
*
|
2005-03-25 |
2011-10-19 |
National Research Council of Canada |
Method for isolation of soluble polypeptides
|
WO2007008848A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
US8343928B2
(en)
|
2005-07-07 |
2013-01-01 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus
|
US7750116B1
(en)
*
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
CN101611318B
(zh)
|
2006-09-07 |
2015-03-04 |
奥塔哥创新有限公司 |
生物标记物
|
SI3339445T1
(sl)
|
2006-09-08 |
2020-12-31 |
Abbvie Bahamas Ltd. |
Beljakovine za vezavo interlevkin-13
|
US7883705B2
(en)
*
|
2007-02-14 |
2011-02-08 |
Kyowa Hakko Kirin Co., Ltd. |
Anti FGF23 antibody and a pharmaceutical composition comprising the same
|
AU2016228280B2
(en)
*
|
2007-07-12 |
2019-02-21 |
Pierre Fabre Medicament |
Novel antibodies inhibiting c-met dimerization, and uses thereof
|
AU2014200629B2
(en)
*
|
2007-07-12 |
2016-10-06 |
Pierre Fabre Medicament |
Novel antibodies inhibiting c-met dimerization, and uses thereof
|
EP2014681A1
(en)
*
|
2007-07-12 |
2009-01-14 |
Pierre Fabre Medicament |
Novel antibodies inhibiting c-met dimerization, and uses thereof
|
WO2009012256A1
(en)
|
2007-07-16 |
2009-01-22 |
Genentech, Inc. |
Humanized anti-cd79b antibodies and immunoconjugates and methods of use
|
ES2381788T3
(es)
|
2007-07-16 |
2012-05-31 |
Genentech, Inc. |
Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
|
US20090035848A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Robert Hickey |
Moving bed biofilm reactor (mbbr) system for conversion of syngas components to liquid products
|
CL2008003561A1
(es)
|
2007-11-30 |
2010-02-05 |
Glaxo Group Ltd |
Construccion de union a il - 13 que comprende a lo menos un dominio simple (dab) de anticuerpo injertado en un anticuerpo monoclonal ( mabdab); polinucleotido y celula huesped; procedimiento para preparar la construccion; composicion farmaceutica que la comprende y uso para tratar cancer o enfermedades inflamatorias.
|
IL287292B
(en)
|
2008-01-31 |
2022-09-01 |
Genentech Inc |
and fusion antibody-drug-cd79b engineered antibodies cysteine-
|
BRPI0906099A2
(pt)
*
|
2008-03-06 |
2015-07-21 |
Genentech Inc |
"método de tratamento do câncer em um indivíduo"
|
TW200942552A
(en)
*
|
2008-03-06 |
2009-10-16 |
Genentech Inc |
Combination therapy with c-Met and HER antagonists
|
US7951549B2
(en)
*
|
2008-03-07 |
2011-05-31 |
Osi Pharmaceuticals, Inc. |
Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
|
DK2265641T3
(en)
*
|
2008-03-12 |
2018-04-23 |
Otago Innovation Ltd |
Biomarkers
|
CA2715921A1
(en)
|
2008-03-12 |
2009-09-17 |
Otago Innovation Limited |
Biomarkers
|
US20100260668A1
(en)
*
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
KR20110014607A
(ko)
*
|
2008-04-29 |
2011-02-11 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
EP2288383A1
(en)
*
|
2008-05-14 |
2011-03-02 |
Amgen, Inc |
Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
|
WO2009142738A2
(en)
*
|
2008-05-21 |
2009-11-26 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
NZ589434A
(en)
*
|
2008-06-03 |
2012-11-30 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
EP2297208A4
(en)
*
|
2008-06-03 |
2012-07-11 |
Abbott Lab |
DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES
|
EP2143441A1
(en)
*
|
2008-07-08 |
2010-01-13 |
Pierre Fabre Medicament |
Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
|
CA2729949A1
(en)
*
|
2008-07-08 |
2010-01-14 |
Abbott Laboratories |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
AU2009300328A1
(en)
*
|
2008-10-01 |
2010-04-08 |
Ludwig Institute For Cancer Research |
Methods for the treatment of cancer
|
TW201019961A
(en)
*
|
2008-10-17 |
2010-06-01 |
Genentech Inc |
Combination therapy
|
CN102216331A
(zh)
*
|
2008-10-17 |
2011-10-12 |
霍夫曼-拉罗奇有限公司 |
治疗方法
|
US9528160B2
(en)
|
2008-11-07 |
2016-12-27 |
Adaptive Biotechnolgies Corp. |
Rare clonotypes and uses thereof
|
US8628927B2
(en)
|
2008-11-07 |
2014-01-14 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
US8748103B2
(en)
|
2008-11-07 |
2014-06-10 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
US9506119B2
(en)
|
2008-11-07 |
2016-11-29 |
Adaptive Biotechnologies Corp. |
Method of sequence determination using sequence tags
|
GB2477439B
(en)
|
2008-11-07 |
2012-02-15 |
Sequenta Inc |
Methods for correlating clonotypes with a disease in a patient
|
US9365901B2
(en)
|
2008-11-07 |
2016-06-14 |
Adaptive Biotechnologies Corp. |
Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
|
PA8849001A1
(es)
*
|
2008-11-21 |
2010-06-28 |
Lilly Co Eli |
Anticuerpos de c-met
|
US8545839B2
(en)
|
2008-12-02 |
2013-10-01 |
Pierre Fabre Medicament |
Anti-c-Met antibody
|
WO2010064089A1
(en)
*
|
2008-12-02 |
2010-06-10 |
Pierre Fabre Medicament |
Novel anti-cmet antibody
|
US9469691B2
(en)
|
2008-12-02 |
2016-10-18 |
Pierre Fabre Medicament |
Anti-cMET antibody
|
AR074439A1
(es)
|
2008-12-02 |
2011-01-19 |
Pf Medicament |
Anticuerpo anti-cmet (receptor c-met)
|
ES2568509T3
(es)
|
2009-01-15 |
2016-04-29 |
Adaptive Biotechnologies Corporation |
Perfilado de la inmunidad adaptativa y métodos para la generación de anticuerpos monoclonales
|
WO2010097394A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Multivalent and/or multispecific rankl-binding constructs
|
US20110305693A1
(en)
|
2009-02-24 |
2011-12-15 |
Glaxo Group Limited |
Anitigen-binding constructs
|
CA2753287A1
(en)
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Antigen-binding constructs
|
HUE061117T2
(hu)
|
2009-03-25 |
2023-05-28 |
Genentech Inc |
Anti-FGFR3 antitestek és eljárások alkalmazásukra
|
AU2010233995A1
(en)
|
2009-04-07 |
2011-09-08 |
Roche Glycart Ag |
Bispecific anti-ErbB-2/anti-c-Met antibodies
|
EP2417159A1
(en)
|
2009-04-07 |
2012-02-15 |
Roche Glycart AG |
Bispecific anti-erbb-3/anti-c-met antibodies
|
US20120058116A1
(en)
|
2009-04-24 |
2012-03-08 |
Andrew Beaton |
Fgfr1c antibody combinations
|
US8496938B2
(en)
|
2009-05-08 |
2013-07-30 |
Vaccinex, Inc. |
Anti-CD100 neutralizing neutralizing antibodies and methods of using the same
|
US20100316639A1
(en)
|
2009-06-16 |
2010-12-16 |
Genentech, Inc. |
Biomarkers for igf-1r inhibitor therapy
|
RU2014144463A
(ru)
|
2009-06-25 |
2015-06-20 |
Фред Хатчинсон Кансэр Рисёч Сентер |
Способ измерения адаптивного иммунитета
|
TW201109438A
(en)
*
|
2009-07-29 |
2011-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
BR112012004710A2
(pt)
*
|
2009-09-01 |
2016-08-16 |
Abbott Lab |
imunoglobulinas de domínio variável duplo e uso das mesmas
|
MX2012004415A
(es)
*
|
2009-10-15 |
2012-05-08 |
Abbott Lab |
Inmunoglobulinas de dominio variable doble y usos de las mismas.
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
KR101671378B1
(ko)
|
2009-10-30 |
2016-11-01 |
삼성전자 주식회사 |
c-Met에 특이적으로 결합하는 항체 및 그의 용도
|
KR101748707B1
(ko)
*
|
2009-11-27 |
2017-06-20 |
삼성전자주식회사 |
c-Met에 특이적으로 결합하는 항체 및 그를 이용한 암 진단용 키트
|
CN103003307B
(zh)
|
2010-03-10 |
2017-08-11 |
根马布股份公司 |
抗c‑MEt的单克隆抗体
|
EP2569014A4
(en)
*
|
2010-05-14 |
2013-11-20 |
Hoffmann La Roche |
PROCESSING METHODS
|
WO2011150454A1
(en)
|
2010-06-01 |
2011-12-08 |
Monash University |
ANTIBODIES DIRECTED TO THE UNPROCESSED RECEPTOR TYROSINE KINASE c-MET
|
IL300712A
(en)
*
|
2010-06-22 |
2023-04-01 |
Regeneron Pharma |
Mice with light chain to human
|
EP2402370A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Pierre Fabre Médicament |
Novel antibody for the diagnosis and/or prognosis of cancer
|
WO2012003338A1
(en)
|
2010-07-01 |
2012-01-05 |
Takeda Pharmaceutical Company Limited |
COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
|
EP2596010B1
(en)
|
2010-07-19 |
2017-04-12 |
Otago Innovation Limited |
Signal biomarkers
|
AU2011285852B2
(en)
|
2010-08-03 |
2014-12-11 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
PE20140229A1
(es)
|
2010-08-26 |
2014-03-27 |
Abbvie Inc |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
SG10201408229WA
(en)
|
2010-08-31 |
2015-02-27 |
Genentech Inc |
Biomarkers and methods of treatment
|
CA2809677A1
(en)
*
|
2010-09-03 |
2012-03-08 |
Academia Sinica |
Anti-c-met antibody and methods of use thereof
|
EP2621483A1
(en)
|
2010-09-27 |
2013-08-07 |
Exelixis, Inc. |
Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
|
US11644471B2
(en)
|
2010-09-30 |
2023-05-09 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
WO2012042026A1
(en)
|
2010-09-30 |
2012-04-05 |
Ablynx Nv |
Biological materials related to c-met
|
EP2635602B1
(en)
|
2010-11-03 |
2016-09-07 |
Argen-X Nv |
Anti c-met antibodies
|
US20130236467A1
(en)
|
2010-11-24 |
2013-09-12 |
Jeremy Griggs |
Multispecific antigen binding proteins targeting hgf
|
WO2012075340A2
(en)
|
2010-12-01 |
2012-06-07 |
Alderbio Holdings Llc |
Anti-ngf compositions and use thereof
|
CN108659121A
(zh)
|
2011-06-23 |
2018-10-16 |
埃博灵克斯股份有限公司 |
用于预测、检测和减少涉及免疫球蛋白单可变结构域的测定法中的非特异性蛋白干扰的技术
|
AU2012271974B2
(en)
*
|
2011-06-23 |
2017-01-12 |
Ablynx Nv |
Serum albumin binding proteins
|
US9890218B2
(en)
*
|
2011-06-30 |
2018-02-13 |
Chugai Seiyaku Kabushiki Kaisha |
Heterodimerized polypeptide
|
MX2013014687A
(es)
|
2011-06-30 |
2014-02-17 |
Genentech Inc |
Formulaciones de anticuerpo anti-c-met.
|
EP2748202B1
(en)
|
2011-08-23 |
2018-07-04 |
Roche Glycart AG |
Bispecific antigen binding molecules
|
EP2748197A2
(en)
|
2011-08-26 |
2014-07-02 |
Merrimack Pharmaceuticals, Inc. |
Tandem fc bispecific antibodies
|
US10385475B2
(en)
|
2011-09-12 |
2019-08-20 |
Adaptive Biotechnologies Corp. |
Random array sequencing of low-complexity libraries
|
CN103930111A
(zh)
|
2011-09-19 |
2014-07-16 |
霍夫曼-拉罗奇有限公司 |
包含c-met拮抗剂和b-raf拮抗剂的组合治疗
|
EP2758430A4
(en)
|
2011-09-20 |
2015-06-03 |
Lilly Co Eli |
ANTI-C-MET ANTIBODY
|
US9346884B2
(en)
|
2011-09-30 |
2016-05-24 |
Ablynx N.V. |
Biological materials related to c-Met
|
CA2850261C
(en)
*
|
2011-09-30 |
2021-04-20 |
Ablynx Nv |
C-met immunoglobulin single variable domains
|
KR101865223B1
(ko)
|
2011-10-05 |
2018-06-08 |
삼성전자주식회사 |
항 c-Met 인간화 항체 및 그의 용도
|
KR20130036993A
(ko)
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
c-Met의 SEMA 도메인 내의 에피토프에 특이적으로 결합하는 항체
|
KR20130037153A
(ko)
*
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
항 c-Met 항체 및 그의 용도
|
MX353550B
(es)
|
2011-10-11 |
2018-01-18 |
Vaccinex Inc |
Uso de moleculas de enlace a semaforina-4d para la modulacion de la permeabilidad de la barrera sangre-cerebro.
|
US9279159B2
(en)
|
2011-10-21 |
2016-03-08 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
EP2773660A2
(en)
|
2011-11-03 |
2014-09-10 |
Argen-X B.V. |
Chimeric human-camel antigens and their use
|
CN104066748A
(zh)
|
2011-11-21 |
2014-09-24 |
霍夫曼-拉罗奇有限公司 |
抗c-met抗体的纯化
|
US20150147274A1
(en)
|
2011-12-02 |
2015-05-28 |
Cancer Research Technology Limited |
Antibodies against hgf - receptor and uses
|
ES2683037T3
(es)
|
2011-12-09 |
2018-09-24 |
Adaptive Biotechnologies Corporation |
Diagnóstico de tumores malignos linfoides y detección de enfermedad residual mínima
|
US9499865B2
(en)
|
2011-12-13 |
2016-11-22 |
Adaptive Biotechnologies Corp. |
Detection and measurement of tissue-infiltrating lymphocytes
|
US8900582B2
(en)
|
2011-12-22 |
2014-12-02 |
Samsung Electronics Co., Ltd. |
Deimmunized anti c-Met humanized antibodies and uses thereof
|
AU2012362326A1
(en)
|
2011-12-30 |
2014-07-24 |
Abbvie Inc. |
Dual variable domain immunoglobulins against IL-13 and/or IL-17
|
DK2823060T3
(en)
|
2012-03-05 |
2018-05-28 |
Adaptive Biotechnologies Corp |
Determination of associated immune receptor chains from frequency-matched subunits
|
ES2661516T3
(es)
|
2012-03-20 |
2018-04-02 |
Otago Innovation Limited |
Biomarcadores
|
WO2013152252A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
US9150905B2
(en)
|
2012-05-08 |
2015-10-06 |
Adaptive Biotechnologies Corporation |
Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
|
US10494440B2
(en)
|
2012-05-11 |
2019-12-03 |
Vaccinex, Inc. |
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
|
JP6628966B2
(ja)
|
2012-06-14 |
2020-01-15 |
中外製薬株式会社 |
改変されたFc領域を含む抗原結合分子
|
CA2877573A1
(en)
*
|
2012-06-21 |
2013-12-27 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind c-met
|
CA2882272C
(en)
|
2012-08-24 |
2023-08-29 |
Chugai Seiyaku Kabushiki Kaisha |
Fc.gamma.riib-specific fc region variant
|
CN105189779B
(zh)
|
2012-10-01 |
2018-05-11 |
适应生物技术公司 |
通过适应性免疫受体多样性和克隆性表征进行的免疫能力评估
|
PT2839860T
(pt)
|
2012-10-12 |
2019-07-29 |
Medimmune Ltd |
Pirrolobenzodiazepinas e conjugados das mesmas
|
WO2015160439A2
(en)
|
2014-04-17 |
2015-10-22 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
SG11201503412RA
(en)
|
2012-11-01 |
2015-05-28 |
Abbvie Inc |
Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
|
EP2727941A1
(en)
|
2012-11-05 |
2014-05-07 |
MAB Discovery GmbH |
Method for the production of multispecific antibodies
|
EP2914629A1
(en)
|
2012-11-05 |
2015-09-09 |
MAB Discovery GmbH |
Method for the production of multispecific antibodies
|
LT3447069T
(lt)
|
2012-11-21 |
2020-12-10 |
Janssen Biotech, Inc. |
Bispecifiniai egfr/c-met antikūnai
|
ES2876009T3
(es)
|
2012-12-27 |
2021-11-11 |
Chugai Pharmaceutical Co Ltd |
Polipéptido heterodimerizado
|
US9856319B2
(en)
|
2012-12-28 |
2018-01-02 |
Abbvie Inc. |
Monovalent binding proteins
|
ITTO20130012A1
(it)
*
|
2013-01-09 |
2014-07-10 |
Metheresis Translational Res S A |
Nuovi frammenti anticorpali, relative composizioni ed usi
|
KR101911048B1
(ko)
|
2013-01-29 |
2018-10-24 |
삼성전자주식회사 |
p53 활성화제 및 c-Met 억제제를 포함하는 병용 투여용 약학 조성물
|
EP2957632B1
(en)
*
|
2013-02-15 |
2020-09-30 |
Perseus Proteomics Inc. |
Anti-cdh3 humanized antibody, drug conjugate thereof, and utilization of same
|
KR20150118159A
(ko)
|
2013-02-22 |
2015-10-21 |
에프. 호프만-라 로슈 아게 |
암의 치료 방법 및 약물 내성의 예방 방법
|
KR20150143458A
(ko)
|
2013-03-06 |
2015-12-23 |
메리맥 파마슈티컬즈, 인크. |
항-C-MET 탠덤 Fc 이중특이적 항체
|
JP6444902B2
(ja)
|
2013-03-13 |
2018-12-26 |
メドイミューン・リミテッドMedImmune Limited |
ピロロベンゾジアゼピン及びその結合体
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
JP2016522793A
(ja)
|
2013-03-15 |
2016-08-04 |
アッヴィ・インコーポレイテッド |
IL−1βおよび/またはIL−17に対して指向された二重特異的結合タンパク質
|
US9535055B2
(en)
|
2013-03-28 |
2017-01-03 |
Samsung Electronics Co., Ltd. |
Marker for determining effects of anti-c-Met antibody and method of determining effects of anti-c-Met antibody using the marker
|
US10214593B2
(en)
|
2013-04-02 |
2019-02-26 |
Samsung Electronics Co., Ltd. |
Anti-idiotype antibody against anti-c-MET antibody
|
AU2014250434B2
(en)
|
2013-04-02 |
2019-08-08 |
Chugai Seiyaku Kabushiki Kaisha |
Fc region variant
|
EP3656392A1
(en)
*
|
2013-06-25 |
2020-05-27 |
Vaccinex, Inc. |
Use of semaphorin-4d inhibitory molecules in combination with an immune modulating therapy to inhibit tumor growth and metastases
|
US9708657B2
(en)
|
2013-07-01 |
2017-07-18 |
Adaptive Biotechnologies Corp. |
Method for generating clonotype profiles using sequence tags
|
NZ630881A
(en)
|
2013-10-10 |
2016-03-31 |
Vaccinex Inc |
Use of semaphorin-4d binding molecules for treatment of atherosclerosis
|
NZ630892A
(en)
|
2013-10-21 |
2016-03-31 |
Vaccinex Inc |
Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
|
AU2015227054A1
(en)
|
2014-03-05 |
2016-09-22 |
Adaptive Biotechnologies Corporation |
Methods using randomer-containing synthetic molecules
|
EP3122900A1
(en)
|
2014-03-24 |
2017-02-01 |
F. Hoffmann-La Roche AG |
Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
|
US10066265B2
(en)
|
2014-04-01 |
2018-09-04 |
Adaptive Biotechnologies Corp. |
Determining antigen-specific t-cells
|
WO2016031412A1
(ja)
*
|
2014-08-25 |
2016-03-03 |
コニカミノルタ株式会社 |
反応方法、検出方法および検出装置
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
CA2961323C
(en)
|
2014-09-16 |
2021-11-30 |
Symphogen A/S |
Anti-met antibodies and compositions
|
EP3689910A3
(en)
|
2014-09-23 |
2020-12-02 |
F. Hoffmann-La Roche AG |
Method of using anti-cd79b immunoconjugates
|
AU2015339191A1
(en)
|
2014-10-29 |
2017-05-18 |
Adaptive Biotechnologies Corp. |
Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
|
CA2961439A1
(en)
|
2014-11-05 |
2016-05-12 |
Genentech, Inc. |
Anti-fgfr2/3 antibodies and methods using same
|
US10246701B2
(en)
|
2014-11-14 |
2019-04-02 |
Adaptive Biotechnologies Corp. |
Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
|
WO2016086029A1
(en)
|
2014-11-25 |
2016-06-02 |
Adaptive Biotechnologies Corporation |
Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
|
EP3229836B1
(en)
|
2014-12-09 |
2019-11-13 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Human monoclonal antibodies against axl
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
EP3233916A4
(en)
|
2014-12-19 |
2018-06-06 |
Alder Biopharmaceuticals, Inc. |
Humanized anti-acth antibodies and use thereof
|
MA41375A
(fr)
|
2015-01-22 |
2017-11-28 |
Lilly Co Eli |
Anticorps igg bispécifiques et leurs procédés de préparation
|
AU2016222788B2
(en)
|
2015-02-24 |
2022-03-31 |
Adaptive Biotechnologies Corp. |
Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
CN107613974B
(zh)
*
|
2015-03-16 |
2021-01-15 |
塞尔德克斯医疗公司 |
抗-met抗体及其使用方法
|
EP3277294B1
(en)
|
2015-04-01 |
2024-05-15 |
Adaptive Biotechnologies Corp. |
Method of identifying human compatible t cell receptors specific for an antigenic target
|
WO2016165580A1
(zh)
*
|
2015-04-17 |
2016-10-20 |
江苏恒瑞医药股份有限公司 |
抗c-Met抗体和抗c-Met抗体-细胞毒性药物偶联物及其医药用途
|
CN106188293A
(zh)
*
|
2015-04-17 |
2016-12-07 |
江苏恒瑞医药股份有限公司 |
抗c-Met抗体和抗c-Met抗体-细胞毒性药物偶联物及其医药用途
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
JP6924708B2
(ja)
*
|
2015-06-29 |
2021-08-25 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
B1sp融合タンパク質の治療薬、方法、および使用
|
ITUB201586501U1
(it)
*
|
2015-10-26 |
2017-04-26 |
Ballarini Paolo & Figli Spa |
Recipiente per la cottura di alimenti
|
CN115925962A
(zh)
*
|
2015-10-30 |
2023-04-07 |
豪夫迈·罗氏有限公司 |
铰链修饰的抗体片段和其制备方法
|
AU2016349152A1
(en)
*
|
2015-11-03 |
2018-06-14 |
Merck Patent Gmbh |
Bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof
|
JP7082604B2
(ja)
|
2016-03-21 |
2022-06-08 |
マレンゴ・セラピューティクス,インコーポレーテッド |
多重特異性および多機能性分子ならびにその使用
|
CN105884897A
(zh)
*
|
2016-04-23 |
2016-08-24 |
同济大学苏州研究院 |
抗c-Met单价抗体慢病毒快速表达及应用
|
GB201611123D0
(en)
|
2016-06-27 |
2016-08-10 |
Euremab Srl |
Anti met antibodiesand uses thereof
|
US10428325B1
(en)
|
2016-09-21 |
2019-10-01 |
Adaptive Biotechnologies Corporation |
Identification of antigen-specific B cell receptors
|
EP3515936A1
(en)
|
2016-09-23 |
2019-07-31 |
Elstar Therapeutics, Inc. |
Multispecific antibody molecules comprising lambda and kappa light chains
|
US20200023072A1
(en)
|
2016-10-11 |
2020-01-23 |
Medimmune Limited |
Antibody-drug conjugates with immune-mediated therapy agents
|
TWI782930B
(zh)
*
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗met抗體,結合met之雙特異性抗原結合分子及其使用方法
|
TW201825515A
(zh)
|
2017-01-04 |
2018-07-16 |
美商伊繆諾金公司 |
Met抗體以及其免疫結合物及用途
|
US20200291089A1
(en)
|
2017-02-16 |
2020-09-17 |
Elstar Therapeutics, Inc. |
Multifunctional molecules comprising a trimeric ligand and uses thereof
|
US20200071417A1
(en)
|
2017-04-19 |
2020-03-05 |
Elstar Therapeutics, Inc. |
Multispecific molecules and uses thereof
|
KR102078292B1
(ko)
*
|
2017-05-30 |
2020-02-19 |
주식회사 종근당 |
신규한 항 c-Met 항체 및 이의 용도
|
EP3630836A1
(en)
|
2017-05-31 |
2020-04-08 |
Elstar Therapeutics, Inc. |
Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof
|
WO2019035938A1
(en)
|
2017-08-16 |
2019-02-21 |
Elstar Therapeutics, Inc. |
MULTISPECIFIC MOLECULES BINDING TO BCMA AND USES THEREOF
|
US11254980B1
(en)
|
2017-11-29 |
2022-02-22 |
Adaptive Biotechnologies Corporation |
Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
|
US20200377571A1
(en)
|
2017-12-08 |
2020-12-03 |
Elstar Therapeutics, Inc. |
Multispecific molecules and uses thereof
|
IT201800000535A1
(it)
|
2018-01-03 |
2019-07-03 |
|
Procedimenti per la cura del cancro.
|
US20210009711A1
(en)
|
2018-03-14 |
2021-01-14 |
Elstar Therapeutics, Inc. |
Multifunctional molecules and uses thereof
|
KR102275930B1
(ko)
|
2018-03-14 |
2021-07-12 |
(주)알테오젠 |
Folr1에 특이적으로 결합하는 항체 및 그의 용도
|
WO2019178362A1
(en)
|
2018-03-14 |
2019-09-19 |
Elstar Therapeutics, Inc. |
Multifunctional molecules that bind to calreticulin and uses thereof
|
US20220111065A1
(en)
|
2018-05-23 |
2022-04-14 |
Adc Therapeutics Sa |
Molecular adjuvant
|
EP3818083A2
(en)
|
2018-07-03 |
2021-05-12 |
Elstar Therapeutics, Inc. |
Anti-tcr antibody molecules and uses thereof
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
JP7465272B2
(ja)
|
2018-09-27 |
2024-04-10 |
マレンゴ・セラピューティクス,インコーポレーテッド |
Csf1r/ccr2多特異性抗体
|
KR102433184B1
(ko)
*
|
2018-12-07 |
2022-08-17 |
서울대학교 산학협력단 |
항 c-Met 아고니스트 항체 및 이의 용도
|
KR102396194B1
(ko)
*
|
2018-12-07 |
2022-05-10 |
서울대학교 산학협력단 |
항 c-Met 아고니스트 항체 및 이의 용도
|
CA3130508A1
(en)
|
2019-02-21 |
2020-08-27 |
Marengo Therapeutics, Inc. |
Antibody molecules that bind to nkp30 and uses thereof
|
JP2022522662A
(ja)
|
2019-02-21 |
2022-04-20 |
マレンゴ・セラピューティクス,インコーポレーテッド |
T細胞に結合する多機能性分子および自己免疫障害を処置するためのその使用
|
CA3131014A1
(en)
|
2019-02-21 |
2020-08-27 |
Andreas Loew |
Anti-tcr antibody molecules and uses thereof
|
JP2022521750A
(ja)
|
2019-02-21 |
2022-04-12 |
マレンゴ・セラピューティクス,インコーポレーテッド |
カルレティキュリンに結合する多機能性分子およびその使用
|
CA3130754A1
(en)
|
2019-02-21 |
2020-08-27 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to t cell related cancer cells and uses thereof
|
CN113727757A
(zh)
|
2019-02-21 |
2021-11-30 |
瑞泽恩制药公司 |
使用结合met的抗-met抗体和双特异性抗原结合分子治疗眼癌的方法
|
AU2020349462A1
(en)
|
2019-09-16 |
2022-03-03 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled MET binding proteins for immuno-PET imaging
|
EP4084821A4
(en)
|
2020-01-03 |
2024-04-24 |
Marengo Therapeutics, Inc. |
CD33-BINDING MULTIFUNCTIONAL MOLECULES AND THEIR USES
|
KR20230028242A
(ko)
|
2020-04-24 |
2023-02-28 |
마렝고 테라퓨틱스, 인크. |
T 세포 관련 암 세포에 결합하는 다중기능성 분자 및 그것의 용도
|
CN112521507B
(zh)
*
|
2020-08-10 |
2021-06-08 |
北京鼎成肽源生物技术有限公司 |
抗人c-Met人鼠嵌合单克隆抗体及其应用
|
AU2021331076A1
(en)
|
2020-08-26 |
2023-04-06 |
Marengo Therapeutics, Inc. |
Antibody molecules that bind to NKp30 and uses thereof
|
KR20230074487A
(ko)
|
2020-08-26 |
2023-05-30 |
마렝고 테라퓨틱스, 인크. |
Trbc1 또는 trbc2를 검출하는 방법
|
AU2021331075A1
(en)
|
2020-08-26 |
2023-04-06 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to calreticulin and uses thereof
|
US20230372528A1
(en)
|
2020-10-16 |
2023-11-23 |
University Of Georgia Research Foundation, Inc. |
Glycoconjugates
|
GB202102396D0
(en)
|
2021-02-19 |
2021-04-07 |
Adc Therapeutics Sa |
Molecular adjuvant
|
CN117157325A
(zh)
|
2021-04-08 |
2023-12-01 |
拜奥迪斯私人有限公司 |
抗c-met抗体和抗体-药物缀合物
|
KR20240004462A
(ko)
|
2021-04-08 |
2024-01-11 |
마렝고 테라퓨틱스, 인크. |
Tcr에 결합하는 다기능성 분자 및 이의 용도
|
WO2024030341A1
(en)
|
2022-07-30 |
2024-02-08 |
Pinetree Therapeutics, Inc. |
Compositions for targeted lysosomal degradaton and methods of use thereof
|
US20240084041A1
(en)
|
2022-09-01 |
2024-03-14 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating non-small cell lung cancer using mesenchymal epithelial transition factor (met)-targeted agents
|
WO2024077118A2
(en)
|
2022-10-06 |
2024-04-11 |
Bicara Therapeutics Inc. |
Multispecific proteins and related methods
|